Biohaven Pharmaceutical
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $3,836 |
Gross Profit | -1,105 | -1,014 | 1,918 | |
EBITDA | -172,117 | -209,723 | -219,315 | -187,470 |
EBIT | -173,222 | -211,701 | -221,561 | -189,931 |
Net Income | -173,443 | -198,147 | -221,677 | -186,843 |
Net Change In Cash | 0 | 0 | 0 | 3,836 |
Free Cash Flow | -145,729 | -168,169 | -165,585 | -170,791 |
Cash | 184,847 | 165,797 | 98,417 | 99,134 |
Basic Shares | 105,815 | 102,372 | 101,943 | 101,055 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $462,509 |
Gross Profit | -3,923 | -3,369 | -1,386 | 370,845 |
EBITDA | -877,256 | -429,139 | -566,546 | -217,507 |
EBIT | -885,111 | -436,051 | -567,932 | -218,900 |
Net Income | -846,422 | -408,168 | -570,279 | -213,796 |
Net Change In Cash | 0 | 0 | 0 | 462,509 |
Cost of Revenue | 40,301 | |||
Free Cash Flow | -586,502 | -334,773 | -338,763 | -146,778 |
Cash | 99,134 | 248,402 | 204,877 | 76,057 |
Basic Shares | 91,234 | 71,201 | 44,741 | 39,375 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-12-31 | $0 |
2025-09-30 | -$1.64 |
2025-06-30 | -$1.94 |
2025-03-31 | -$2.17 |
